Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention

Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention

Mortality and morbidity in patients with ST elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI) are still high [1]. A huge amount of the myocardial damage is related to the mitochondrial events happening during reperfusion [2]. Several drugs directly...

Full description

Bibliographic Details
Main Authors: Gianluca Campo, Rita Pavasini, Giampaolo Morciano, Michael A. Lincoff, Michael C. Gibson, Masafumi Kitakaze, Jacob Lonborg, Amrita Ahluwalia, Hideki Ishii, Michael Frenneaux, Michel Ovize, Marcello Galvani, Dan Atar, Borja Ibanez, Giampaolo Cerisano, Simone Biscaglia, Brandon J. Neil, Masanori Asakura, Thomas Engstrom, Daniel A. Jones, Dana Dawson, Roberto Ferrari, Paolo Pinton, Filippo Ottani
Format: Article
Language:English
Published: Elsevier 2017-10-01
Series:Data in Brief
Subjects:
Reperfusion injury
Myocardial infarction
PCI
Cyclosporin
Nicorandil
Follow-up
Online Access:http://www.sciencedirect.com/science/article/pii/S2352340917303359

Internet

http://www.sciencedirect.com/science/article/pii/S2352340917303359

Similar Items